SCHEMBL3623356

SCHEMBL3623356

COc1cc(C(O)C(Cl)(Cl)Cl)cc(C(O)C(Cl)(Cl)Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CYP3A4 P08684 1/20 0.37
AOC3 Q16853 2/20 0.35
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PKM P14618 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
ABL1 P00519 1/20 0.32
ABCB1 P08183 1/20 0.32
BCR P11274 1/20 0.32
GABBR2 O75899 1/20 0.32
GABBR1 Q9UBS5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3617945 0.83 AOC3 (0.51) ALDH1A1L3MBTL1TSHRMAPK1TDP1
SCHEMBL7127057 0.81 ALDH1A1 (0.64) ALDH1A1L3MBTL1TSHRMAPK1TDP1
SCHEMBL3623954 0.80 ALDH1A1 (0.47) ALDH1A1L3MBTL1TSHRMAPK1TDP1
SCHEMBL7120793 0.78 ABL1 (0.42) TSHRCA1CA2CYP3A4PKM
SCHEMBL19667841 0.75 ALDH1A1 (0.48) ALDH1A1L3MBTL1TSHRCA1CA2
SCHEMBL7131005 0.72 TUBB1 (0.50) L3MBTL1TSHRTDP1CYP3A4
SCHEMBL16372527 0.72 ALDH1A1 (0.58) ALDH1A1L3MBTL1CA1CA2CYP3A4
SCHEMBL15215671 0.72 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPK1CA1CA2
SCHEMBL1818480 0.72 ALDH1A1 (0.58) ALDH1A1L3MBTL1CA1CA2CYP3A4
SCHEMBL7120855 0.70 BACE1 (0.40) TSHRCYP3A4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517879-B1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK SHARP & DOHME (US) 2014-06-04 EP disclosed
US-7834062-B2 Aminoalkylphenols, methods of using and making the same MERCK SHARP & DOHME CORP. (US) 2010-11-16 US disclosed
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK SHARP & DOHME LLC 2009-12-03 US disclosed
US-7589127-B2 Aminoalkylphenols, methods of using and making the same MERCK & CO., INC. (US) 2009-09-15 US disclosed
EP-1517879-A4 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK & CO INC (US) 2006-09-13 EP disclosed
US-20050234265-A1 Aminoalkylphenols, methods of using and making the same MERCK SHARP & DOHME LLC 2005-10-20 US disclosed
EP-1517879-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME Merck & Co., Inc. (US) 2005-03-30 EP disclosed
WO-2004000783-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME MERCK & CO., INC. (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298949-A1 AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME NPEPPS, PHOSPHO1, LNPEP ALDH1A1 1120/4885L3MBTL1 1753/4885TSHR 4709/4885
US-20050234265-A1 Aminoalkylphenols, methods of using and making the same NPEPPS, PHOSPHO1, LNPEP ALDH1A1 1120/4885L3MBTL1 1753/4885TSHR 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.